Importantly, we observed a high correlation of quantification of the HER2/CEP17 ratio and the average of HER2 and CEP17 copy number per cell between visual and IA measurements of cancer cases without statistically significant differences, confirming equivalency between methodologies. This evidence concerns the gene ERBB2 and cancer.